As of 2026-04-03, the Relative Valuation of TG Therapeutics Inc (TGTX) is 42.63 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.53 USD, the upside of TG Therapeutics Inc based on Relative Valuation is 27.2%.
The range of the Relative Valuation is 15.58 - 70.23 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 25.1x | 24.2x |
| Forward P/E multiples | 21.7x - 31.1x | 24.5x |
| Fair Price | 15.58 - 70.23 | 42.63 |
| Upside | -53.5% - 109.5% | 27.2% |
| Date | P/E |
| 2026-04-01 | 11.99 |
| 2026-03-31 | 11.86 |
| 2026-03-30 | 11.25 |
| 2026-03-27 | 11.34 |
| 2026-03-26 | 11.42 |
| 2026-03-25 | 11.36 |
| 2026-03-24 | 10.79 |
| 2026-03-23 | 10.87 |
| 2026-03-20 | 10.74 |
| 2026-03-19 | 10.84 |
| 2026-03-18 | 10.73 |
| 2026-03-17 | 11.25 |
| 2026-03-16 | 10.27 |
| 2026-03-13 | 9.98 |
| 2026-03-12 | 9.62 |
| 2026-03-11 | 10.02 |
| 2026-03-10 | 10.45 |
| 2026-03-09 | 10.42 |
| 2026-03-06 | 10.45 |
| 2026-03-05 | 10.37 |
| 2026-03-04 | 10.42 |
| 2026-03-03 | 10.31 |
| 2026-03-02 | 10.50 |
| 2026-02-27 | 10.75 |
| 2026-02-26 | 11.03 |
| 2026-02-25 | 10.59 |
| 2026-02-24 | 10.90 |
| 2026-02-23 | 10.92 |
| 2026-02-20 | 10.55 |
| 2026-02-19 | 10.52 |
| 2026-02-18 | 10.44 |
| 2026-02-17 | 10.38 |
| 2026-02-13 | 10.18 |
| 2026-02-12 | 10.15 |
| 2026-02-11 | 10.29 |
| 2026-02-10 | 10.41 |
| 2026-02-09 | 10.56 |
| 2026-02-06 | 10.31 |
| 2026-02-05 | 9.91 |
| 2026-02-04 | 10.40 |
| 2026-02-03 | 10.62 |
| 2026-02-02 | 10.42 |
| 2026-01-30 | 10.51 |
| 2026-01-29 | 10.71 |
| 2026-01-28 | 10.82 |
| 2026-01-27 | 11.00 |
| 2026-01-26 | 10.96 |
| 2026-01-23 | 11.14 |
| 2026-01-22 | 11.30 |
| 2026-01-21 | 11.27 |